Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS)

Antiviral Research

Volumn 91, Issue 2, 2011, Pages 150-153

  García, Federico ^a   Pérez Cachafeiro, Santiago ^b   Guillot, Vicente ^a   Alvarez, Marta ^a   Pérez Romero, Pilar ^c   Pérez Elías, María Jesús ^d   Viciana, Isabel ^e   Blanco, Jose Ramón ^f   López Dieguez, Maria ^g   de Mendoza, Carmen ^h  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^f HOSPITAL SAN PEDRO   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

CoRIS; HIV; Non B subtypes; Transmitted drug resistance

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CLADISTICS; EASTERN EUROPE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NORTH AFRICA; PRIORITY JOURNAL; REVERTANT; SPAIN; VIRUS GENE; VIRUS MUTATION; VIRUS TRANSMISSION;

ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HUMANS; MALE; MUTATION; PREVALENCE; SPAIN; VIRAL LOAD;

EID: 79959250845     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.05.010     Document Type: Article

References (19)

1. Bannister W.P., Cozzi-Lepri A., Clotet B., Mocroft A., Kjaer J., Reiss P., von Wyl V., Lazzarin A., Katlama C., Phillips A.N., Ruiz L., Lundgren J.D. EuroSIDA study group, transmitted drug resistant human immunodeficiency virus type 1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA study. J. Acquir. Immune. Defic. Syndr. 2008, 48(3):324-333.
2. Bennett D.E., Camacho R.J., Otelea D., Kuritzkes D.R., Fleury H., Kiuchi M., Heneine W., Kantor R., Jordan M.R., Schapiro J.M., Vandamme A.M., Sandstrom P., Boucher C.A., van de Vijver D., Rhee S.Y., Liu T.F., Pillay D., Shafer R.W. Drug resistance mutations for sulveillance of transmitted human immunodeficiency virus type 1 drug-resistance. 2009 update. PloS One 2009, 4(3):e4724.
3. Caro-Murillo A.M., Castilla J., Pérez-Hoyos S., Miró J.M., Podzamczer D., Rubio R., Riera M., Viciana P., López Aldeguer J., Iribarren J.A., de los Santos-Gil I., Gómez-Sirvent J.L., Berenguer J., Gutiérrez F., Saumoy M., Segura F., Soriano V., Peña A., Pulido F., Oteo J.A., Leal M., Casabona J., del Amo J., Moreno S. Grupo de trabajo de la Cohorte de la Red de Investigación en Sida (CoRIS), Spanish cohort of naïve human immunodeficiency virus infected patients (CoRIS): rationale, organization and initial results. Enferm. Infecc. Microbiol. Clin. 2007, 25(1):23-31.
4. de Mendoza C., Rodriguez C., Colomina J., Tuset C., Garcia F., Eiros J.M., Corral A., Leiva P., Aguero J., Torre-Cisneros J., Pedreira J., Viciana I., del Romero J., Saez A., Ortiz de Lejarazu R., Soriano V., Seroconverter Spanish.H.I.V., Group Study. Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of human immunodeficiency virus type 1 non-B subtypes are increasing among persons with recent infection in Spain. Clin. Infect. Dis. 2005, 41(9):1350-1354.
5. Expert Committee of GESIDA and the National AIDS Plan. Recommendations of GESIDA/Spanish AIDS Plan on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2007). Enferm Infec. Microbiol. Clin. 2007; 25:32-53.
6. Fox J., Castro H., Kaye S., McClure M., Weber J., Fidler S. Epidemiology of non-B clade forms of human immunodeficiency virus type 1 in men who have sex with men in the UK. AIDS 2010, 24(15):2397-2401. On behalf of the UK Collaborative Group on Drug Resistance, [Epub ahead of print].
7. Galimand J., Frange P., Rouzioux C., Deveau C., Avettand-Fenoël V., Ghosn J., Lascoux C., Goujard C., Meyer L., Chaix M.L. Evidence of human immunodeficiency virus type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France. ANRS CO06 PRIMO Cohort. AIDS Res. Hum. Retroviruses 2010, 26(6):645-651.
8. Gifford R., de Oliveira T., Rambaut A., Myers R.E., Gale C.V., Dunn D., Shafer R., Vandamme A.M., Kellam P., Pillay D. Assessment of automated genotyping protocols as tools for surveillance of human immunodeficiency virus type 1 genetic diversity. AIDS 2006, 20(11):1521-1529. UK Collaborative Group on HIV Drug Resistance.
9. Lai A., Riva C., Marconi A., Balestrieri M., Razzolini F., Meini G., Vicenti I., Rosi A., Saladini F., Caramma I., Franzetti M., Rossini V., Galli A., Galli M., Violin M., Zazzi M., Balotta C. Changing patterns in human immunodeficiency virus type 1 non-B clade prevalence and diversity in Italy over three decades. HIV Med. 2010, 11(9):593-602. [Epub ahead of print].
10. Palma A.C., Araujo F., Duque V., Borges F., Paixao M., Camacho R., Network Portuguese.Spread. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed human immunodeficiency virus type 1 patients in Portugal. Infect. Genet. Evol. 2007, 7(3):391-398.
11. Ragonnet-Cronin M., Ofner-Agostini M., Merks H., Pilon R., Rekart M., Archibald C.P., Sandstrom P.A., Brooks J.I. Longitudinal phylogenetic surveillance identifies distinct patterns of cluster dynamics. J. Acquir. Immune. Defic. Syndr. 2010, 55(1):102-108. [Epub ahead of print].
12. Recordon-Pinson P., Anies G., Bruyand M., Neau D., Morlat P., Pellegrin J.L., Groppi A., Thiébaut R., Dabis F., Fleury H., Masquelier B., RS A.N. Human immunodeficiency virus type 1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity. Antivir. Ther. 2009, 14(4):551-556. CO3 Aquitaine Cohort.
13. Sax P., Islam R., Walensky R., Losina E., Weinstein M., Goldie S., Sadownik S., Freedberg A. Should resistance testing be performed for treatment-naive HIV-infected patients? a cost-effectiveness analysis. Clin. Infect. Dis. 2005, 41(9):1316-1323. 10.1086/49698.
14. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular evolutionary genetics analysis (MEGA) Software version 4.0. Mol. Biol. Evol. 2007, 24(8):1596-1599.
15. Truong H.M., Grant R.M., McFarland W., Kellogg T., Kent C., Louie B., Wong E., Klausner J.D. Routine surveillance for the detection of acute and recent human immunodeficiency virus infections and transmission of antiretroviral resistance. AIDS 2006, 20(17):2193-2197.
16. Vercauteren J., Wensing A.M., van de Vijver D.A., Albert J., Balotta C., Hamouda O., Kücherer C., Struck D., Schmit J.C., Asjö B., Bruckova M., Camacho R.J., Clotet B., Coughlan S., Grossman Z., Horban A., Korn K., Kostrikis L., Nielsen C., Paraskevis D., Poljak M., Puchhammer-Stöckl E., Riva C., Ruiz L., Salminen M., Schuurman R., Sonnerborg A., Stanekova D., Stanojevic M., Vandamme A.M., Boucher C.A. Transmission of drug-resistant human immunodeficiency virus type 1 is stabilizing in Europe. J. Infect. Dis. 2009, 200(10):1503-1508.
17. Weinstock H.S., Zaidi I., Heneine W., Bennett D., Garcia-Lerma J.G., Douglas J.M., LaLota M., Dickinson G., Schwarcz S., Torian L., Wendell D., Paul S., Goza G.A., Ruiz J., Boyett B., Kaplan J.E. The epidemiology of antiretroviral drug resistance among drug-naive human immunodeficiency virus type 1 infected persons in 10 US cities. J. Infect. Dis. 2004, 189(12):2174-2180.
18. Wittkop, L., Günthard, H., de Wolf, F., Dunn, D., Cozzi-Lepri, A., de Luca, A., Kücherer, C., Obel, N., von Wyl, V., Masquelier, B., Stephan, C., Torti, C., Antinori, A., García, F., Judd, A., Porter, K., Thiébaut, R., Castro, H., van Sighem, A., Colin, C., Kjaer, J., Lundgren, J., Paredes, R., Pozniak, A., Clotet., B, Phillips, A., Pillay, D., Chêne, G., for the EuroCoord-CHAIN study group, 2011. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis (Article in Press DOI: 10.1016/S1473-3099(11)70032-9).
19. Yerly S., von Wyl V., Ledergerber B., Böni J., Schüpbach J., Bürgisser P., Klimkait T., Rickenbach M., Kaiser L., Günthard H.F., Perrin L. Transmission of human immunodeficiency virus type 1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS 2007, 21(16):2223-2229. Swiss HIV Cohort Study.